QuickMD review

QuickMD is best understood as access to a prescribing consultation rather than a medication-included weight-loss subscription. Its weight-care page currently advertises a $99 encounter, no required membership and prescriptions sent to a local pharmacy when medically appropriate. That can be attractive if a patient wants a recognizable branded treatment and already has a pharmacy or drug benefit to investigate. It does not establish a $99 monthly cost for GLP-1 treatment. The actual medicine, pharmacy availability, insurance coverage and future clinical visits determine ongoing spending. The biggest practical limitation is that the completed consultation is a paid medical service even when the clinician declines the desired prescription. Someone whose budget depends on a particular covered product should check the insurance formulary and pharmacy before booking. The weight-loss page excludes Louisiana, so general national-service messaging should not replace the condition-specific eligibility check.

QuickMD is a broader telehealth service with separate treatment pathways for weight management and other health concerns. Its current weight-care page lists branded prescription options and describes licensed doctors assessing goals, history and budget. The separate medication listings do not mean every listed drug has the same approved indication or that a clinician will choose the patient’s preferred product. For comparison purposes, the central business distinction is that QuickMD provides the consultation and sends a prescription to a pharmacy; it does not include the pharmacy’s medication charge in the advertised visit fee. That also means there is no single dispensing pharmacy to name for every patient. The chosen pharmacy becomes an additional participant in checking stock, coverage, labeling and dispensing. The website provides a general state directory, but its weight-loss page gives the more specific Louisiana exclusion. Confirm where you will physically be during the consultation and whether that location is eligible at booking.

The patient books an online appointment and discusses suitability with a clinician. Same-day appointments and seven-day availability are advertised, but the presence of a booking link is not a guarantee that a particular clinician, time or medication is available. Prepare current medication information, previous GLP-1 use and relevant records so that the visit can address treatment decisions rather than only missing information. Ask whether laboratory work is required, how results will reach the clinician and which tests or follow-ups would incur separate charges. The program page notes that some established patients may qualify for a 90-day prescription. That is a clinical possibility, not a three-month supply promise or a fixed quarterly care price. Before leaving the appointment, establish when another evaluation is needed, how side effects should be reported and what route to use if the pharmacy requests clarification. This model asks the patient to participate in coordinating the consultation and pharmacy rather than relying on a bundled refill shipment. For a patient already receiving GLP-1 care, a transfer visit should establish who will handle future monitoring and prescription changes. Ask whether the proposed supply duration matches the follow-up interval and whether another encounter is needed if the pharmacy cannot fill the chosen product. A new consultation fee can materially change the value of an otherwise convenient one-time visit.

The verified public weight-loss consultation price is $99 per visit. Medication is explicitly excluded and varies with the prescribed product, pharmacy and drug benefits. We therefore do not enter that fee as a medication-inclusive monthly price floor. A meaningful budget should separate the encounter cost, frequency of future encounters, any required laboratory charges and the actual recurring pharmacy payment. Insurance that covers a medication is also different from insurance paying for this telehealth encounter. Ask QuickMD about the visit’s payment arrangements and the insurer about the drug, rather than assuming one answer covers both. The refund policy says a completed visit is not refundable simply because a requested medication is deemed inappropriate. Missed, canceled or unsuccessful visits generally receive account credit, with refund eligibility described for those credits within 30 days. Missing an appointment or canceling less than one hour before its start can deduct a $35 fee from that credit. Review the selected booking and policy before purchasing, particularly if an appointment time may change or the visit depends on obtaining records first.

QuickMD’s published weight-care menu includes products such as Wegovy, Zepbound, Ozempic, Mounjaro and Rybelsus. These names establish the service’s advertised prescription discussion, rather than a promise that every product is suitable, covered or in stock. The clinician should identify the exact formulation and explain the proposed indication before sending a prescription. Do not treat a diabetes product and an obesity product as administratively interchangeable simply because they share a molecule; coverage requirements and the clinical decision can differ. The local-pharmacy model gives the patient a direct contact for confirming the dispensed product, instructions and price. It also leaves stock checks and some insurance coordination outside the visit itself. QuickMD’s weight-loss projections and trial-based marketing do not predict an individual outcome or establish results for the consultation service. The useful comparison is whether this paid encounter offers sufficient follow-up and medication access for the patient’s situation, compared with a primary-care visit or a program that charges a separate ongoing care fee.